Biopharmaceuticals and ethics in rheumatology

Abstract

The purpose of this review is to set an analysis on Brazilian rheumatologists’ ethical commitment in face of prescription of high cost drugs, chronic use and exceptional dispensation, the biologics. The author departs from a reflection about the factors that influence therapeutic decision making, the grounds for legal suits related to these drugs and their impact on public health policies.